The latest update is out from Reviva Pharmaceuticals Holdings (RVPH).
Reviva Pharmaceuticals Holdings, Inc. has embarked on a financial maneuver with Titan Partners Group LLC, launching a public offering of over 3 million shares, pre-funded and regular warrants, with the aim of raising approximately $4.1 million. The transaction, set to close around August 22, 2024, features warrants with a five-year expiration and special provisions adjusting exercise prices and ownership caps. The offering, part of a larger strategy detailed in legal documentation and subject to standard closing conditions, reflects the company’s forward-looking statements and market-driven aspirations.
See more data about RVPH stock on TipRanks’ Stock Analysis page.
